التفاصيل البيبلوغرافية
| العنوان: |
Absorption, distribution, metabolism, and excretion of [14C]TPN729 after oral administration to rats. |
| المؤلفون: |
Cheng, Huan, Yu, Jinghua, Yang, Chen, Zhang, Ning, Fan, Zhen, Zhang, Xiaojuan, Wang, Junchen, Wang, Zhen, Zhong, Da-fang, He, Ji-Xiang, Yan, Shu, Diao, Xingxing |
| المصدر: |
Xenobiotica; Jan2022, Vol. 52 Issue 1, p79-90, 12p |
| مصطلحات موضوعية: |
EXCRETION, METABOLISM, BLOOD plasma, RATS, LARGE intestine, BILE, PENILE erection |
| مصطلحات جغرافية: |
CHINA |
| مستخلص: |
TPN729, a novel phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED), is in phase II clinical trials in China. Previous studies suggested that TPN729 possesses promising therapeutic value. In previous non-radiolabeled rat excretion studies, the recovery of TPN729 and its major metabolites accounted for approximately 8.58% of the administration dose in urine and faeces by 48 h post-dose. To solve this problem and further study the metabolism of TPN729 in rats, we used the radio-isotopic tracing technique for the first time. In this study, the mass balance, tissue distribution, and metabolism of TPN729 were evaluated in rats after a single oral dose of 25 mg/kg [14C]TPN729 (150 μCi/kg). At 168 h post-dose, the mean total radioactivity recovery of the dose was 92.13%. Faeces was the major excretion route, accounting for 74.63% of the dose, and urine excretion accounted for 17.50%. After oral administration of [14C]TPN729, radioactivity was widely distributed in all examined tissues, and a higher radioactivity concentration was observed in the stomach, large intestine, lung, liver, small intestine, and eyes. The concentration of drug-related materials were similar in plasma and blood cells. A total of 51 metabolites were identified in rat plasma, urine, faeces, and bile, and the predominant metabolically susceptible position of TPN729 was the pyrrolidine moiety. The main metabolic pathways were N-dealkylation, oxidation, and dehydrogenation. In summary, we solved the previous problem of low drug recovery, elucidated the major excretion pathway, determined the tissue distribution patterns, and investigated the metabolism of TPN729 in rats by using a radioisotopic tracing technique. [ABSTRACT FROM AUTHOR] |
|
Copyright of Xenobiotica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher